414 related articles for article (PubMed ID: 24641806)
21. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
[TBL] [Abstract][Full Text] [Related]
23. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
[TBL] [Abstract][Full Text] [Related]
24. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
[TBL] [Abstract][Full Text] [Related]
25. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
[TBL] [Abstract][Full Text] [Related]
26. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.
Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R
ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186
[TBL] [Abstract][Full Text] [Related]
27. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.
Long EF; Swain GW; Mangi AA
Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of high-urgency heart transplant patients with and without temporary ventricular assist device support.
Castel MA; Cartañá R; Cardona M; Pereda D; Hernández M; Sandoval E; Castella M; Pérez-Villa F
Transplant Proc; 2012 Nov; 44(9):2642-4. PubMed ID: 23146481
[TBL] [Abstract][Full Text] [Related]
29. Left ventricular assist devices.
Birks EJ
Heart; 2010 Jan; 96(1):63-71. PubMed ID: 19617213
[TBL] [Abstract][Full Text] [Related]
30. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
[TBL] [Abstract][Full Text] [Related]
31. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.
Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP
J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726
[TBL] [Abstract][Full Text] [Related]
32. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
[TBL] [Abstract][Full Text] [Related]
33. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
[TBL] [Abstract][Full Text] [Related]
34. Mechanical circulatory support in severe heart failure: single-center experience.
Vitali E; Lanfranconi M; Bruschi G; Ribera E; Garatti A; Colombo T; Russo CF
Transplant Proc; 2004 Apr; 36(3):620-2. PubMed ID: 15110613
[TBL] [Abstract][Full Text] [Related]
35. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
Urban M; Pirk J; Dorazilova Z; Netuka I
Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
[TBL] [Abstract][Full Text] [Related]
36. Screening for heart transplantation and left ventricular assist system: results from the ScrEEning for advanced Heart Failure treatment (SEE-HF) study.
Lund LH; Trochu JN; Meyns B; Caliskan K; Shaw S; Schmitto JD; Schibilsky D; Damme L; Heatley J; Gustafsson F
Eur J Heart Fail; 2018 Jan; 20(1):152-160. PubMed ID: 28960673
[TBL] [Abstract][Full Text] [Related]
37. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension.
Nair PK; Kormos RL; Teuteberg JJ; Mathier MA; Bermudez CA; Toyoda Y; Dew MA; Simon MA
J Heart Lung Transplant; 2010 Feb; 29(2):201-8. PubMed ID: 20113910
[TBL] [Abstract][Full Text] [Related]
38. Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices.
Emani S; Tumin D; Foraker RE; Hayes D; Smith SA
Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 27862317
[TBL] [Abstract][Full Text] [Related]
39. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
[TBL] [Abstract][Full Text] [Related]
40. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
